Lex

No deal means both AstraZeneca and Pfizer will lose

Pfizer's fourth and 'final' takeover approach for the UK pharmaceuticals group has been rejected. Lex's Joseph Cotterill and Robert Armstrong discuss where this leaves the two companies.